# Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only

Source: https://onco.cc/trials/nct06867705/  
OnCo record `nct06867705` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Resilience PRO in advanced solid tumours, run by Resilience, now recruiting.

## Summary

Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only is a phase 3 interventional study registered as NCT06867705 by Resilience, with 1458 participants planned, started 2025-04-01 and due to reach its primary completion in 2027-01. Interventions recorded: Resilience PRO.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06867705
- Phase: 3
- Setting: Digital Monitoring With Patient-Reported Outcomes in Cancer Care: A Randomized Controlled Trial RC - 102 (Resilience Care - 102)
- Sponsor: Resilience
- Enrolled: 1458

## Sources

- ClinicalTrials.gov NCT06867705: https://clinicaltrials.gov/study/NCT06867705

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct06867705.json